BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33655712)

  • 1. SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis.
    Cao Y; Li P; Wang H; Li L; Li Q
    Cancer Med; 2021 Feb; 10(4):1394-1404. PubMed ID: 33655712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer.
    Wang X; Zeng Q; Li Z; Yang X; Xia W; Chen Z
    Thorac Cancer; 2019 Apr; 10(4):642-658. PubMed ID: 30779316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis.
    Bo W; Yu N; Wang X; Wang C; Liu C
    Neoplasia; 2024 Feb; 48():100960. PubMed ID: 38184887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
    An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
    Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis.
    Guo R; Li Y; Xue Y; Chen Y; Li J; Deng X; Su J; Liu Y; Sun L
    Gene; 2020 Jun; 745():144629. PubMed ID: 32229158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circ-Foxo3 inhibits esophageal squamous cell cancer progression via the miR-23a/PTEN axis.
    Xing Y; Zha WJ; Li XM; Li H; Gao F; Ye T; Du WQ; Liu YC
    J Cell Biochem; 2020 Mar; 121(3):2595-2605. PubMed ID: 31680314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia.
    Tseng AH; Wu LH; Shieh SS; Wang DL
    Biochem J; 2014 Nov; 464(1):157-68. PubMed ID: 25162939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
    Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
    J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim.
    Sun T; Zhang J; Deng B; Fan X; Long T; Jin H; Tao S; Kang P; Tan Q
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1348-1359. PubMed ID: 33167006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
    Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
    BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-specific protease 3 attenuates interleukin-1β-mediated chondrocyte senescence by deacetylating forkhead box O-3 via sirtuin-3.
    Zhou Q; Wang W; Wu J; Qiu S; Yuan S; Fu PL; Qian QR; Xu YZ
    Bioengineered; 2022 Feb; 13(2):2017-2027. PubMed ID: 34847835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia.
    Rangarajan P; Karthikeyan A; Lu J; Ling EA; Dheen ST
    Neuroscience; 2015 Dec; 311():398-414. PubMed ID: 26523980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol rescues cadmium-induced mitochondrial injury by enhancing transcriptional regulation of PGC-1α and SOD2 via the Sirt3/FoxO3a pathway in TCMK-1 cells.
    Fu B; Zhao J; Peng W; Wu H; Zhang Y
    Biochem Biophys Res Commun; 2017 Apr; 486(1):198-204. PubMed ID: 28286268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1.
    Zhang Y; Xing Y; Zhang L; Mei Y; Yamamoto K; Mak TW; You H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5717-22. PubMed ID: 22451935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM60A promotes cisplatin resistance in lung cancer cells by activating SKP2 expression.
    Hou Q; Jiang Z; Li Y; Wu H; Yu J; Jiang M
    Anticancer Drugs; 2020 Sep; 31(8):776-784. PubMed ID: 32796403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
    Gao Z; Li Z; Liu Y; Liu Z
    Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.